Доцетаксел засяга не само раковите клетки, но и нераковите като кръвните клетки, което може да предизвика нежелани реакции.
Taxotere/ Docetaxel Winthrop has been studied in one main study involving over 3,000 women with HER2-expressing breast cancer that could be treated with surgery.